Summary
ctDNA analysis is now a widely used diagnostic approach in the management of patients with solid tumors, including gene fusion–driven lung cancer. However, the accurate detection of genetic rearrangements in ctDNA presents considerable technical challenges. Consequently, studies that assess and compare methodologies for detection are vital.
This content is only available via PDF.
©2025 American Association for Cancer Research
2025
American Association for Cancer Research
You do not currently have access to this content.